Filed: 7/9/2026ACC: 0001951757-26-000944
📋 What this filing means
PSP RESEARCH LLC filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $187.88M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$187.88M
Total AUM (reported)
2.04M
Total Shares
Allocation by class
ST STR SP BIOT$90.20M48.0%
0-3 MTH TREASURY$70.47M37.5%
COM$21.16M11.3%
COM NEW$1.38M0.7%
SHS CLASS A$616.8K0.3%
SPONSORED ADR$594.7K0.3%
ADS$480.7K0.3%
Portfolio Concentration
Top 3$161.29M85.8%
4–10$4.10M2.2%
11–25$7.63M4.1%
Rest$14.86M7.9%
Top 3 weight
85.8%
Top 10 weight
88.0%
Voting Authority Distribution
Total shares with voting rights: 2.04M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
2.04M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings75
Rows:
SPDR SERIES TRUST
SOLEShares570K
TypeSH
Market value$90.20M
48.01%
Sole
0.00
Shared
0.00
None
570K
ISHARES TR
SOLEShares700K
TypeSH
Market value$70.47M
37.51%
Sole
0.00
Shared
0.00
None
700K
ROYALTY PHARMA PLC
SOLEShares11K
TypeSH
Market value$616.8K
0.33%
Sole
0.00
Shared
0.00
None
11K
NURIX THERAPEUTICS INC
SOLEShares25K
TypeSH
Market value$606.5K
0.32%
Sole
0.00
Shared
0.00
None
25K
INCYTE CORP
SOLEShares5.30K
TypeSH
Market value$600.8K
0.32%
Sole
0.00
Shared
0.00
None
5.30K
ARGENX SE
SOLEShares641.00
TypeSH
Market value$594.7K
0.32%
Sole
0.00
Shared
0.00
None
641.00
DISC MEDICINE INC
SOLEShares8K
TypeSH
Market value$585.1K
0.31%
Sole
0.00
Shared
0.00
None
8K
RAPPORT THERAPEUTICS INC
SOLEShares14K
TypeSH
Market value$583.4K
0.31%
Sole
0.00
Shared
0.00
None
14K
ULTRAGENYX PHARMACEUTICAL IN
SOLEShares17K
TypeSH
Market value$567.6K
0.30%
Sole
0.00
Shared
0.00
None
17K
TREVI THERAPEUTICS INC
SOLEShares30K
TypeSH
Market value$559.5K
0.30%
Sole
0.00
Shared
0.00
None
30K
MONTE ROSA THERAPEUTICS INC
SOLEShares23K
TypeSH
Market value$556.6K
0.30%
Sole
0.00
Shared
0.00
None
23K
TG THERAPEUTICS INC
SOLEShares10K
TypeSH
Market value$549.4K
0.29%
Sole
0.00
Shared
0.00
None
10K
HALOZYME THERAPEUTICS INC
SOLEShares7K
TypeSH
Market value$547.9K
0.29%
Sole
0.00
Shared
0.00
None
7K
IONIS PHARMACEUTICALS INC
SOLEShares6.80K
TypeSH
Market value$539.2K
0.29%
Sole
0.00
Shared
0.00
None
6.80K
PHARVARIS N V
SOLEShares15K
TypeSH
Market value$518.7K
0.28%
Sole
0.00
Shared
0.00
None
15K
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares19.70K
TypeSH
Market value$516.5K
0.27%
Sole
0.00
Shared
0.00
None
19.70K
AURINIA PHARMACEUTICALS INC
SOLEShares30K
TypeSH
Market value$509.1K
0.27%
Sole
0.00
Shared
0.00
None
30K
NEUROCRINE BIOSCIENCES INC
SOLEShares3K
TypeSH
Market value$505.6K
0.27%
Sole
0.00
Shared
0.00
None
3K
IMMUNOVANT INC
SOLEShares13K
TypeSH
Market value$500.9K
0.27%
Sole
0.00
Shared
0.00
None
13K
ACADIA PHARMACEUTICALS INC
SOLEShares19.77K
TypeSH
Market value$500.1K
0.27%
Sole
0.00
Shared
0.00
None
19.77K
PTC THERAPEUTICS INC
SOLEShares6K
TypeSH
Market value$489.4K
0.26%
Sole
0.00
Shared
0.00
None
6K
CELLDEX THERAPEUTICS INC NEW
SOLEShares13K
TypeSH
Market value$483.7K
0.26%
Sole
0.00
Shared
0.00
None
13K
IMMUNOCORE HLDGS PLC
SOLEShares15.14K
TypeSH
Market value$480.7K
0.26%
Sole
0.00
Shared
0.00
None
15.14K
DEFINIUM THERAPEUTICS INC
SOLEShares10K
TypeSH
Market value$470.4K
0.25%
Sole
0.00
Shared
0.00
None
10K
COGENT BIOSCIENCES INC
SOLEShares12K
TypeSH
Market value$464.4K
0.25%
Sole
0.00
Shared
0.00
None
12K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUSTSOLE | ST STR SP BIOT | 570K | SH | $90.20M 48.01% | 0.00 | 0.00 | 570K |
ISHARES TRSOLE | 0-3 MTH TREASURY | 700K | SH | $70.47M 37.51% | 0.00 | 0.00 | 700K |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 11K | SH | $616.8K 0.33% | 0.00 | 0.00 | 11K |
NURIX THERAPEUTICS INCSOLE | COM | 25K | SH | $606.5K 0.32% | 0.00 | 0.00 | 25K |
INCYTE CORPSOLE | COM | 5.30K | SH | $600.8K 0.32% | 0.00 | 0.00 | 5.30K |
ARGENX SESOLE | SPONSORED ADR | 641.00 | SH | $594.7K 0.32% | 0.00 | 0.00 | 641.00 |
DISC MEDICINE INCSOLE | COM | 8K | SH | $585.1K 0.31% | 0.00 | 0.00 | 8K |
RAPPORT THERAPEUTICS INCSOLE | COM | 14K | SH | $583.4K 0.31% | 0.00 | 0.00 | 14K |
ULTRAGENYX PHARMACEUTICAL INSOLE | COM | 17K | SH | $567.6K 0.30% | 0.00 | 0.00 | 17K |
TREVI THERAPEUTICS INCSOLE | COM | 30K | SH | $559.5K 0.30% | 0.00 | 0.00 | 30K |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 23K | SH | $556.6K 0.30% | 0.00 | 0.00 | 23K |
TG THERAPEUTICS INCSOLE | COM | 10K | SH | $549.4K 0.29% | 0.00 | 0.00 | 10K |
HALOZYME THERAPEUTICS INCSOLE | COM | 7K | SH | $547.9K 0.29% | 0.00 | 0.00 | 7K |
IONIS PHARMACEUTICALS INCSOLE | COM | 6.80K | SH | $539.2K 0.29% | 0.00 | 0.00 | 6.80K |
PHARVARIS N VSOLE | COM | 15K | SH | $518.7K 0.28% | 0.00 | 0.00 | 15K |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 19.70K | SH | $516.5K 0.27% | 0.00 | 0.00 | 19.70K |
AURINIA PHARMACEUTICALS INCSOLE | COM | 30K | SH | $509.1K 0.27% | 0.00 | 0.00 | 30K |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 3K | SH | $505.6K 0.27% | 0.00 | 0.00 | 3K |
IMMUNOVANT INCSOLE | COM | 13K | SH | $500.9K 0.27% | 0.00 | 0.00 | 13K |
ACADIA PHARMACEUTICALS INCSOLE | COM | 19.77K | SH | $500.1K 0.27% | 0.00 | 0.00 | 19.77K |
PTC THERAPEUTICS INCSOLE | COM | 6K | SH | $489.4K 0.26% | 0.00 | 0.00 | 6K |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 13K | SH | $483.7K 0.26% | 0.00 | 0.00 | 13K |
IMMUNOCORE HLDGS PLCSOLE | ADS | 15.14K | SH | $480.7K 0.26% | 0.00 | 0.00 | 15.14K |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 10K | SH | $470.4K 0.25% | 0.00 | 0.00 | 10K |
COGENT BIOSCIENCES INCSOLE | COM | 12K | SH | $464.4K 0.25% | 0.00 | 0.00 | 12K |
Page 1 of 3